We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Unique Barcoding System Tracks Pneumonia-Causing Bacteria as They Infect Blood Stream

By LabMedica International staff writers
Posted on 28 Feb 2025

Bacteremia, also known as blood poisoning, occurs when bacteria manage to overcome the body's immune defenses. More...

This condition can progress into sepsis, a serious illness that is responsible for over a third of hospital-related deaths each year. While individuals are frequently exposed to bacteria from the environment, they often fight off these infections without experiencing this deadly progression. Scientists are working to understand how bacteria spread throughout the body to cause systemic infections, with the ultimate goal of halting this process before it escalates.

Researchers at U-M Medical School (Ann Arbor, MI, USA) have been investigating this issue, focusing on gram-negative bacteria such as Klebsiella pneumoniae, a common cause of pneumonia-related bacteremia. In their previous studies, they identified three stages in the spread of bacteria: initial infection at a site like the lungs, entry into the bloodstream, and replication while avoiding filtration by the liver and spleen. Traditionally, bacterial infections are analyzed by culturing tissue and counting the resulting bacteria. While it’s easy to measure the initial infection phase by observing how bacteria invade the lungs, and similarly, the third phase by assessing how bacteria survive in the liver and spleen, the transition from the lungs into the bloodstream has been difficult to track.

Using an innovative barcoding system, the researchers labeled bacteria with short DNA sequences in mouse models and employed computer analysis to track the movement of K. pneumoniae throughout the body. They initially hypothesized that the bacteria would replicate in the lungs until they overwhelmed the local immune defenses, eventually spilling into the bloodstream. This type of spread, which they called metastatic dissemination, was observed in some mice. However, they also uncovered an unexpected pattern. About half of the mice showed this metastatic pattern, while the other half exhibited a form of bacterial spread where the bacteria entered the bloodstream on their own without first replicating in large numbers, a process they termed direct dissemination.

The findings, published in Nature Communications, revealed that the metastatic pathway was associated with a more severe infection compared to the direct dissemination route. Moreover, over time, the infection tended to follow the metastatic pattern. The discovery of the direct route suggests that bacteria might be establishing low-level reservoirs in other parts of the body, which could offer new targets for treating blood infections. Additionally, the researchers introduced mutations in both the K. pneumoniae bacteria and the mice, which affected the mode of bacterial dissemination. This hinted that the interaction between the bacteria and the host’s immune system could play a key role in determining the course of the infection.

“The project began with a very basic question—how does bacteria leave the lungs—that we have now provided some insight into, closing a significant gap in our knowledge,” said Michael Bachman, M.D., Ph.D., clinical associate professor of pathology and microbiology and immunology at U-M Medical School.


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Pipette Controller
Sapphire MaxiPette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.